Dance Well Therapy: a Study for Evaluating Efficacy, Safety, and Feasibility
DWpsVMF
Studio Sulla Fattibilità e Sul Potenziale Riabilitativo Dell'Esperienza Artistica di Dance Well Nei Pazienti Affetti da Malattia di Parkinson
1 other identifier
interventional
24
1 country
1
Brief Summary
A new and in-teresting complementary approach for rehabilitation of parkinsonian patients is represented by "Dance Well", which is an artistic, multisensory dance intervention based on art and music. This study aims to evaluate the efficacy, feasibility, and safety of a 4-week Dance Well (DW) program in PD patients in early-medium disease stages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jan 2022
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedMarch 26, 2025
March 1, 2025
5 months
March 10, 2025
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
UPDRS III
UPDRS III (Unified Parkinson's Disease Rating Scale, Part III) is a clinical tool used to assess motor function in Parkinson's disease patients. It evaluates symptoms such as tremors, rigidity, bradykinesia, postural stability, gait, and rapid alternating movements. Each item is scored from 0 (no impairment) to 4 (severe impairment), with the total score indicating the overall severity of motor symptoms.
Form the enrollment to the end of treatment at 4 weeks
Secondary Outcomes (8)
Berg Balance Scale (BBS)
Form the enrollment to the end of treatment at 4 weeks
6-Minute Walk Test (6MWT)
Form the enrollment to the end of treatment at 4 weeks
Timed Up and Go (TUG) Test
Form the enrollment to the end of treatment at 4 weeks
Corsi Supra-Span Block Tapping Test
Form the enrollment to the end of treatment at 4 weeks
Trail Making Test (TMT) A and B-A
Form the enrollment to the end of treatment at 4 weeks
- +3 more secondary outcomes
Study Arms (2)
DanceWell Group
EXPERIMENTAL12 PD patients underwent 4-week Dance Well Program
Conventional Therapy Group
ACTIVE COMPARATOR12 PD patients underwent 4-week Conventional Therapy Program
Interventions
DW is specifically designed for people with early to mild severe PD and aims to de-liver multiple stimuli, including rhythmical auditory cues, proprioceptive and sensorimo-tor stimulation, balance training, and aerobic exercise, using carefully selected music to cue movement and promote relaxation. The components of DW are relatively simple and easy to be learned and performed for people with compromised mobility. The intervention is also enjoyable and engaging, as reported for other genres of dance
Conventional Motor Therapy consisted on 60-minute conventional physiotherapy, twice a week, for four weeks
Eligibility Criteria
You may qualify if:
- diagnosis of PD according to the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria; rate score 0-3 on the modified Hoehn \& Yahr (H\&Y) scale.
You may not qualify if:
- other neurological or psychiatric diseases other than PD;
- serious visual and/or auditory deficits;
- orthopedic-muscular and or co-morbid medical conditions precluding partici-pation in dance;
- cognitive decline (MoCA score \< 13,8)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fresco Parkinson Center - Villa Margherita (KOS group)
Arcugnago, VI, 36057, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President of KOS Medical Group
Study Record Dates
First Submitted
March 10, 2025
First Posted
March 26, 2025
Study Start
January 7, 2022
Primary Completion
May 31, 2022
Study Completion
September 30, 2022
Last Updated
March 26, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data (IPD) due to concerns related to patient privacy and data security. Ensuring the confidentiality and protection of our participants' personal information is a top priority. Additionally, the resources required to anonymize and manage data sharing securely are not available for this study